Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
26.47
-0.22 (-0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alamar Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -29.82 | -47.07 |
| Depreciation & Amortization | 2.76 | 2.29 |
| Other Amortization | 1.29 | 0.98 |
| Loss (Gain) From Sale of Investments | -0.12 | -1.89 |
| Stock-Based Compensation | 2.87 | 0.87 |
| Other Operating Activities | 1.98 | 1.59 |
| Change in Accounts Receivable | -5.5 | -5.1 |
| Change in Inventory | -23.78 | -8.75 |
| Change in Accounts Payable | -0.57 | 2.92 |
| Change in Other Net Operating Assets | -2.72 | -1.06 |
| Operating Cash Flow | -53.61 | -55.21 |
| Capital Expenditures | -5.37 | -2.95 |
| Sale (Purchase) of Intangibles | -1.01 | -0.44 |
| Investment in Securities | 52.56 | -50.55 |
| Investing Cash Flow | 46.18 | -53.93 |
| Long-Term Debt Issued | 10 | - |
| Long-Term Debt Repaid | - | -15 |
| Net Debt Issued (Repaid) | 10 | -15 |
| Issuance of Common Stock | 1.49 | 0.94 |
| Other Financing Activities | -0.66 | - |
| Financing Cash Flow | 10.84 | 113.42 |
| Foreign Exchange Rate Adjustments | -0.17 | -0 |
| Net Cash Flow | 3.23 | 4.27 |
| Free Cash Flow | -58.98 | -58.16 |
| Free Cash Flow Margin | -79.48% | -231.33% |
| Free Cash Flow Per Share | -2.11 | -2.02 |
| Cash Interest Paid | 0.13 | 2.05 |
| Levered Free Cash Flow | -49.7 | - |
| Unlevered Free Cash Flow | -49.65 | - |
| Change in Working Capital | -32.57 | -11.99 |
Source: S&P Capital IQ. Standard template.
Financial Sources.